ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.060
-0.040 (-1.90%)
At close: Aug 10, 2026, 4:00 PM EDT
2.055
-0.005 (-0.24%)
After-hours: Aug 10, 2026, 7:34 PM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $284.85 million as of August 10, 2026. Its market cap has increased by 687.51% in one year.
Market Cap
284.85M
Enterprise Value
157.66M
1-Year Change
687.51%
Ranking
Category
Stock Price
$2.06
ChartMarket Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $284.85M, a decrease of -73.03%. That is a compound annual growth rate of -19.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 284.85M | 364.94% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 300.16M |
| Zentalis Pharmaceuticals | 297.44M |
| Surrozen | 295.31M |
| Immuneering | 293.08M |
| InflaRx | 288.69M |
| Bicycle Therapeutics | 287.67M |
| Fulcrum Therapeutics | 286.11M |
| Turn Therapeutics | 285.97M |